Femorofemoral bypass grafts: Analysis of patency and factors influencing long-term outcome Enrique Criado, MD, Steven J. Burnham, MD, Ellis A. Tinsley, MD, George Johnson, MD, Blair A. Keagy, MD Journal of Vascular Surgery Volume 18, Issue 3, Pages 495-505 (September 1993) DOI: 10.1016/0741-5214(93)90268-Q Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 1 Life-table analysis of patient survival after FFBPG. Five-year survival rate was 74% ± 7.4%. Survival curve starts at 95.5% because of 4.5% in-hospital mortality rate. Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 2 Life-table analysis of FFBPG primary graft patency (see Table V). Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 3 Comparison of limb salvage rates after FFBPG in patients undergoing surgery for claudication with that in patients who underwent operation for limb-threatening ischemia. Significantly higher amputation rate was noted in patients with limb-threatening ischemia starting at 6 months. Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 4 Comparison of graft patency after FFBPG in patients with patent recipient limb SFA with that in patients with occluded SFA. No significant difference was noted. In view of small number of observations made after 2 years in group of patients with SFA occlusion, these data should be interpreted with caution. More than one half of patients with SFA occlusion underwent concomitant outflow procedures whereas only 17% of those with patent SFA did. Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 5 Comparison of FFBPG primary patency in 48 patients who underwent concomitant outflow procedure with 62 patients who did not have concomitant procedure. Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 6 Comparison of FFBPG primary graft patency in 62 patients who underwent operation for claudication with 44 patients who underwent operation for limb-threatening ischemia (rest pain or tissue necrosis). Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Fig. 7 Comparison of FFBPG primary graft patency in 24 patients who underwent preoperative donor iliac artery PTA with 82 patients who did not undergo preoperative PTA. Trend toward lower graft patency in patients with preoperative PTA did not reach significance. However, small number of grafts observed in this group does not allow firm conclusions. Journal of Vascular Surgery 1993 18, 495-505DOI: (10.1016/0741-5214(93)90268-Q) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions